Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:00 pm Sale | 2022-12-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | Cormorant Asset Management LP | 1,391,663 9.990% | -36,935 (-2.59%) | Filing History |
| 2022-12-29 4:15 pm Purchase | 2022-12-19 | 13G | 89BIO INC ETNB | Cormorant Asset Management LP | 2,550,000 5.480% | 2,550,000 (New Position) | Filing History |
| 2022-12-27 4:15 pm Purchase | 2022-12-14 | 13G | AVIDITY BIOSCIENCES INC RNAM | Cormorant Asset Management LP | 2,762,115 5.070% | 750,000 (+37.27%) | Filing History |
| 2022-12-21 4:32 pm Purchase | 2022-12-13 | 13D | ERASCA INC ERAS | Cormorant Asset Management LP | 10,893,107 7.260% | 387,554 (+3.69%) | Filing History |
| 2022-10-31 4:01 pm Purchase | 2022-10-20 | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management LP | 2,000,000 7.810% | 845,576 (+73.25%) | Filing History |
| 2022-09-02 4:10 pm Purchase | 2022-08-23 | 13G | ASTRIA THERAPEUTICS INC ATXS | Cormorant Asset Management LP | 1,200,000 5.380% | 1,200,000 (New Position) | Filing History |
| 2022-08-29 4:00 pm Purchase | 2022-08-18 | 13G | ARCELLX INC ACLX | Cormorant Asset Management LP | 2,200,000 5.020% | 2,200,000 (New Position) | Filing History |
| 2022-07-07 4:01 pm Purchase | 2022-06-27 | 13G | ALTIMMUNE INC ALT | Cormorant Asset Management LP | 3,000,000 6.130% | 3,000,000 (New Position) | Filing History |
| 2022-06-17 4:30 pm Purchase | 2021-12-31 | 13G | VECTIVBIO HLDG AG VECT | Cormorant Asset Management LP | 2,840,389 6.160% | 2,840,389 (New Position) | Filing History |
| 2022-06-06 5:50 pm Purchase | 2022-06-03 | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cormorant Asset Management LP | 2,224,847 5.680% | 376,825 (+20.39%) | Filing |
| 2022-02-14 3:18 pm Purchase | 2022-02-02 | 13G | GREENLIGHT BIOSCIENCES HLDGS P GRNA | Cormorant Asset Management LP | 9,479,058 7.720% | 9,479,058 (New Position) | Filing History |
| 2022-02-14 3:17 pm Purchase | 2021-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | Cormorant Asset Management LP | 4,899,184 5.600% | 4,899,184 (New Position) | Filing History |
| 2022-02-14 3:16 pm Purchase | 2021-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Cormorant Asset Management LP | 1,381,932 9.990% | 42,301 (+3.16%) | Filing History |
| 2022-02-14 3:15 pm Sale | 2021-12-31 | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cormorant Asset Management LP | 1,848,022 4.750% | -250,000 (-11.92%) | Filing |
| 2022-02-14 3:14 pm Sale | 2021-12-31 | 13G | GALECTO INC GLTO | Cormorant Asset Management LP | 40,810 4.040% | -45,219 (-52.56%) | Filing History |
| 2022-02-14 3:13 pm Purchase | 2021-12-31 | 13G | FORMA THERAPEUTICS HLDGS INC FMTX | Cormorant Asset Management LP | 4,639,998 9.790% | 179,998 (+4.04%) | Filing History |
| 2022-02-14 3:12 pm Sale | 2021-12-31 | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management LP | 1,154,424 4.070% | -750,000 (-39.38%) | Filing History |
| 2022-02-14 3:11 pm Sale | 2021-12-31 | 13G | C4 THERAPEUTICS INC CCCC | Cormorant Asset Management LP | 0 0.000% | -2,490,065 (Position Closed) | Filing History |
| 2022-02-14 3:10 pm Sale | 2021-12-31 | 13G | AEROVATE THERAPEUTICS INC AVTE | Cormorant Asset Management LP | 52,305 7.500% | -5,715 (-9.85%) | Filing History |
| 2022-02-14 3:10 pm Sale | 2021-12-31 | 13G | REVOLUTION MEDICINES INC RVMD | Cormorant Asset Management LP | 2,431,852 3.300% | -1,243,148 (-33.83%) | Filing History |